Is there a place for immunotherapy for tumors with oncogenic driver mutations?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Prof. Dr. T. Berghmans, Institut Jules Bordet, Bruxelles
Dr. F. Aboubakar Nana, Cliniques Universitaires St-Luc, Bruxelles
Dr. M. Brandao, Institut Jules Bordet, Bruxelles